Ads
related to: alzheimer and dementia journal subscription plans costAmerica's Most Trusted Source for News - Pew Research Center
Search results
Results from the WOW.Com Content Network
The American Journal of Alzheimer's Disease & Other Dementias is abstracted and indexed in, among other databases: SCOPUS, and the Social Sciences Citation Index. According to the Journal Citation Reports, its 2010 impact factor is 1.774, ranking it 104 out of 185 journals in the category 'Clinical Neurology'.
For example, the US National Institutes of Health program for Alzheimer's research, the National Plan to Address Alzheimer’s Disease, has a budget of US$3.98 billion for fiscal year 2026. [31] In the European Union , the 2020 Horizon Europe research programme awarded over €570 million for dementia-related projects.
Alzheimer Disease and Associated Disorders is a quarterly peer-reviewed medical journal publishing original research findings and new approaches to diagnosis and treatment for Alzheimer's disease and related disorders. Articles published emphasize research in humans including epidemiologic studies, clinical trials and experimental studies ...
The Journal of Alzheimer's Disease is a peer-reviewed medical journal published by IOS Press covering the etiology, pathogenesis, epidemiology, genetics, treatment, and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor ...
The report contains case studies of national dementia plans and information on health service responses, including recommendations that provide a global framework for action on dementia. N.B Prevalence and cost data contained within the publication have been superseded by the WHO Global Status Report on the Public Health Response to Dementia [41]
Dementia: The International Journal of Social Research and Practice is a bimonthly peer-reviewed academic journal that covers research in the field of dementia studies. Its editors-in-chief are Dr. Pamela Roach (University of Calgary) [1] and Dr. Caroline Swarbrick (University of Lancaster) [2] .
For premium support please call: 800-290-4726 more ways to reach us
The Alzheimer's Impact Movement (AIM) is a separately incorporated 501(c)(4) advocacy affiliate of the Alzheimer's Association. AIM works to secure policies to overcome Alzheimer's and dementia, including increased investment in research, improved care and support, and development of approaches to reduce the risk of developing dementia.
Ads
related to: alzheimer and dementia journal subscription plans costAmerica's Most Trusted Source for News - Pew Research Center